| Nov 19 |
Relmada Therapeutics to Present at Jefferies London Healthcare Conference
|
| Nov 14 |
Relmada Therapeutics Initiates Phase 1 Dosing with REL-P11 for Metabolic Disease
|
| Nov 11 |
Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024
|
| Nov 10 |
Relmada Therapeutics, Inc. (RLMD) Q3 2024 Earnings Call Transcript
|
| Nov 8 |
Relmada Therapeutics Inc (RLMD) Q3 2024 Earnings Call Highlights: Navigating Financial ...
|
| Nov 7 |
Relmada Therapeutics GAAP EPS of -$0.72 misses by $0.08
|
| Nov 7 |
Relmada Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Nov 4 |
Relmada Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024
|
| Oct 22 |
3 US Penny Stocks To Monitor In October 2024
|
| Sep 17 |
Relmada jumps as Jefferies upgrades on a potential turnaround story
|
